Loading
Total declarations
Companies
▲ Purchases (6 ops.)
▼ Sales (1 ops.)
Latest filing published 16 Jun 2025 for Biocryst Pharmaceuticals INC. Read the official filing
Filing timeline
BuySaleNancy J. Hutson
Insider track record
Disclosed buys
6
Disclosed sells
1
T+90 hit rate
100%
T+90 mean return
+47.7%
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Nancy J. Hutson: trading record in brief
Nancy J. Hutson (board member) discloses dealings in 4 companies, chiefly Biocryst Pharmaceuticals Inc, Clearside Biomedical, Inc. and PhaseBio Pharmaceuticals Inc. The record holds 18 filings, for trades running from 28 May 2021 to 12 June 2025.
Market trades split into 6 purchases (€106k) and 1 sale (€50k). Taken together, the purchases exceed the sales by €56k. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Other entries cover 6 share grants and 5 option exercises.
In size, the median ticket on the buying side is €11k. On 3 out of 5 purchases, another insider of the same company was buying within the same 30 days. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time.
On 16 June 2025 came the latest disclosure, a share grant in Biocryst Pharmaceuticals Inc. The last insider purchase was made public on 22 May 2024, 879 days ago. Filings reach the SEC (Form 4) feed a median of 3 days after the trade. For comparison, the SEC allows two business days to file a Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Nancy J. Hutson
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations18 total
12,500 shares0Common StockSEC:0001171843-25-003914:0
7,000 shares@ US$7.5418.2% of flowCommon StockSEC:0001127602-24-029494:0
6,820 shares0Common StockSEC:0001127602-24-018720:0
5,000 shares@ US$6.3810.6% of flowCommon StockSEC:0001127602-24-016190:0
Canonical exit: 18 Aug 2024 (T+90)
10,000 shares@ US$0.865.1% of flowCommon StockSEC:0001209191-23-052027:0
Canonical exit: 1 Jan 2024 (T+90)
16,745 shares0Common StockSEC:0001127602-23-018775:0
3,750 sharesCommon StockSEC:0001169245-23-000027:0
30,000 shares@ US$1.3323.8% of flowCommon StockSEC:0001209191-22-058025:0
Canonical exit: 15 Feb 2023 (T+90)
12,866 shares0Common StockSEC:0001127602-22-017163:0
3,000 shares@ US$3.086.5% of flowCommon StockSEC:0001169245-22-000067:0
Canonical exit: 16 Nov 2021 (T+90)
24,860 shares@ US$2.2686.0% of flowCommon StockSEC:0001169245-21-000106:0
25,000 shares@ US$2.0041.2% of flowCommon StockSEC:0001209191-21-062427:0
30,000 shares@ US$2.9142.1% of flowCommon StockSEC:0001127602-21-027342:0
3,000 shares@ US$3.0814.0% of flowCommon StockSEC:0001169245-21-000083:0
Canonical exit: 16 Nov 2021 (T+90)
3,000 shares@ US$5.6813.9% of flowCommon StockSEC:0001209191-21-051883:0
Canonical exit: 14 Nov 2021 (T+90)
47,924 shares0Ordinary SharesSEC:0001593034-21-000079:0
8,333 shares@ US$2.8510.9% of flowCommon StockSEC:0001127602-21-019792:0
317 shares@ US$15.772.3% of flowCommon StockSEC:0001127602-21-018492:0
18 of 18 declarations
